Jump to content

PubMed RSS Feed - -mTORC1-Mediated Angiogenesis is Required for the Development of Rosacea


Recommended Posts

Front Cell Dev Biol. 2021 Dec 21;9:751785. doi: 10.3389/fcell.2021.751785. eCollection 2021.


Although multiple evidences suggest that angiogenesis is associated with the pathophysiology of rosacea, its role is still in debate. Here, we showed that angiogenesis was enhanced in skin lesions of both rosacea patients and LL37-induced rosacea-like mice. Inhibition of angiogenesis alleviated LL37-induced rosacea-like features in mice. Mechanistically, we showed that mTORC1 was activated in the endothelial cells of the lesional skin from rosacea patients and LL37-induced rosacea-like mouse model. Inhibition of mTORC1 decreased angiogenesis and blocked the development of rosacea in mice. On the contrary, hyperactivation of mTORC1 increased angiogenesis and exacerbated rosacea-like phenotypes. Our in vitro results further demonstrated that inhibition of mTORC1 signaling significantly declined LL37-induced tube formation of human endothelial cells. Taken together, our findings revealed that mTORC1-mediated angiogenesis responding to LL37 might be essential for the development of rosacea and targeting angiogenesis might be a novel potential therapy.

PMID:34993194 | PMC:PMC8724421 | DOI:10.3389/fcell.2021.751785

{url} = URL to article • Cytokines and Rosacea • Mast Cells and the Innate Immune System Disorder • Cathelicidin Peptide LL-37 and Vitamin D3

If you experience error messages on the above links into our member area of the site, you may register an account to view the content.

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Create New...

Important Information

Terms of Use